Floatz logo

FLUOROURACILUM

Neoplasm Recurrence, Local

Light Sciences OncologySmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Neoplasm Recurrence, Local cohort.

Asset / SponsorPhaseRating
Irinotecan
Light Sciences Oncology
Phase 3BB
Levoleucovorin
Light Sciences Oncology
Phase 3BB
Calcium folinate pentahydrate
Light Sciences Oncology
Phase 3BB

Same molecule, other indications

FLUOROURACILUM is also rated in:

colon carcinomaDormant
A
Indicative ·
82 / 100
View asset →
Unresectable or Metastatic Colorectal CancerDormant
BBB
Indicative ·
79 / 100
View asset →
exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →